Chularat Hospital Past Earnings Performance
Past criteria checks 3/6
Chularat Hospital has been growing earnings at an average annual rate of 7.4%, while the Healthcare industry saw earnings growing at 11.8% annually. Revenues have been growing at an average rate of 10.5% per year. Chularat Hospital's return on equity is 14.5%, and it has net margins of 13.1%.
Key information
7.4%
Earnings growth rate
7.4%
EPS growth rate
| Healthcare Industry Growth | 23.6% |
| Revenue growth rate | 10.5% |
| Return on equity | 14.5% |
| Net Margin | 13.1% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Chularat Hospital makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 8,733 | 1,147 | 986 | 0 |
| 30 Jun 24 | 8,520 | 1,056 | 988 | 0 |
| 31 Mar 24 | 8,332 | 1,070 | 969 | 0 |
| 31 Dec 23 | 8,014 | 1,046 | 911 | 0 |
| 30 Sep 23 | 7,643 | 1,058 | 923 | 0 |
| 30 Jun 23 | 7,574 | 990 | 929 | 0 |
| 31 Mar 23 | 8,558 | 1,662 | 931 | 0 |
| 31 Dec 22 | 10,408 | 2,778 | 935 | 0 |
| 30 Sep 22 | 12,526 | 4,306 | 798 | 0 |
| 30 Jun 22 | 14,883 | 5,611 | 884 | 0 |
| 31 Mar 22 | 14,166 | 5,309 | 866 | 0 |
| 31 Dec 21 | 11,999 | 4,204 | 821 | 0 |
| 30 Sep 21 | 9,589 | 2,645 | 911 | 0 |
| 30 Jun 21 | 6,598 | 1,363 | 743 | 0 |
| 31 Mar 21 | 5,612 | 942 | 679 | 0 |
| 31 Dec 20 | 5,462 | 877 | 673 | 0 |
| 30 Sep 20 | 5,270 | 757 | 653 | 0 |
| 30 Jun 20 | 5,241 | 744 | 648 | 0 |
| 31 Mar 20 | 5,277 | 712 | 672 | 0 |
| 31 Dec 19 | 5,188 | 705 | 672 | 0 |
| 30 Sep 19 | 4,998 | 683 | 670 | 0 |
| 30 Jun 19 | 4,715 | 565 | 644 | 0 |
| 31 Mar 19 | 4,575 | 620 | 595 | 0 |
| 31 Dec 18 | 4,427 | 634 | 570 | 0 |
| 30 Sep 18 | 4,305 | 648 | 559 | 0 |
| 30 Jun 18 | 4,187 | 665 | 547 | 0 |
| 31 Mar 18 | 4,038 | 606 | 555 | 0 |
| 31 Dec 17 | 3,894 | 565 | 551 | 0 |
| 30 Sep 17 | 3,790 | 571 | 518 | 0 |
| 30 Jun 17 | 3,721 | 563 | 511 | 0 |
| 31 Mar 17 | 3,705 | 560 | 505 | 0 |
| 31 Dec 16 | 3,655 | 564 | 495 | 0 |
| 30 Sep 16 | 3,595 | 575 | 477 | 0 |
| 30 Jun 16 | 3,436 | 536 | 465 | 0 |
| 31 Mar 16 | 3,326 | 562 | 449 | 0 |
| 31 Dec 15 | 3,171 | 538 | 427 | 0 |
| 30 Sep 15 | 3,020 | 508 | 402 | 0 |
| 30 Jun 15 | 2,904 | 514 | 380 | 0 |
| 31 Mar 15 | 2,783 | 490 | 368 | 0 |
| 31 Dec 14 | 2,695 | 481 | 359 | 0 |
| 30 Sep 14 | 2,580 | 476 | 339 | 0 |
| 30 Jun 14 | 2,497 | 475 | 323 | 0 |
| 31 Mar 14 | 2,374 | 448 | 301 | 0 |
| 31 Dec 13 | 2,234 | 414 | 287 | 0 |
Quality Earnings: CHG-R has high quality earnings.
Growing Profit Margin: CHG-R's current net profit margins (13.1%) are lower than last year (13.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CHG-R's earnings have grown by 7.4% per year over the past 5 years.
Accelerating Growth: CHG-R's earnings growth over the past year (8.5%) exceeds its 5-year average (7.4% per year).
Earnings vs Industry: CHG-R earnings growth over the past year (8.5%) did not outperform the Healthcare industry 11.1%.
Return on Equity
High ROE: CHG-R's Return on Equity (14.5%) is considered low.